antineoplastics I – Flashcards
Unlock all answers in this set
Unlock answersquestion
what is 5-flouro-uracil 5-FU used for? is it complexed w/anything? |
answer
5-FU is very commonly used in solid tumors. it is complexed with regimine (and other anti-neoplastic agents) |
question
what is cytarabine used for? what is it? |
answer
leukemias, lymphomas - it is a purine analogue that is incorporated into DNA and disrupts synthesis |
question
what are alkylating agents used for? |
answer
solid tumors and lymphomas |
question
what do platinum analogues do? |
answer
form adducts w/DNA |
question
what is asparginase? how does it work? |
answer
breaks down asparginase (cancer cells don't have asparagine synthetase and get it from the diet) |
question
what is placitaxel? when is it used, what does it do? |
answer
an alkaloid that is used in solid tumors, it inhibits cell division in M phase |
question
what are protein tyrosine kinase inhibitors? |
answer
protein tyrosine kinase inhibitors such as herceptin have a specific protein which can be targeted with an antibody |
question
what are topoisomerase inhibitors used for? what is an example of one? |
answer
lymphomas. etoposide is an example of one used for lymphomas, doxorubicin forms free radicals to break DNA but has cardio toxicities |
question
what is methotrexate used for? what cells can it affect other than tumor cells? |
answer
methotrexate is active against solid tumors by inhibiting dihydrofolate reductase (blocks folic acid production needed for DNA synthesis). other fast growing cells besides tumor cells such as bone marrow, hair, GI epithelium, and mucosal are also affected by methotrexate |
question
what is 6-mercaptopurine? what is it used for? |
answer
this adosine analogue is incorporated as a mercaptoadosine adduct and confuses DNA polymerase. 6-mercaptopurine is used for lymphomas and & leukemias - NOT solid tumors |
question
what is the implication of the log-kill hypothesis? |
answer
it takes several cycles to get the level of cancer cells down to zero (from 10^9 -> 10^8 is one log kill) so early prevention helps reduce this necessity, along with sx and radiation |
question
what is the primary treatment for hematologic and diffuse cancers (eg leukemias?) |
answer
chemotherapy |
question
when is chemotherapy used? |
answer
chemotherapy can be used as adjuvant therapy after surgery and radiation of solid tumors, initial therapy before surgery to downstage breast cancer, as chemoprotection in high risk individuals |
question
what is selective toxicity? |
answer
aiming directly at cancer modality (though some normal cells will be affected), monoclonal antibodies can are better with this or working with tyrosine kinase |
question
what chemotherapy agents target the M (mitotic) phase? |
answer
alkaloids such as vinicristine and vinblastine |
question
what antimetabolits inhibit the S phase? |
answer
methotrexate and 5-FU |
question
what chemo drugs target the G2 phase? |
answer
etoposide and bleomycin |
question
what drugs are non phase specific? |
answer
alkylating drugs, nitrosources, antitumor antibx, procarbazine, cisplatin, and dacarbazine |
question
what are common toxicities of chemotherapy? |
answer
anemia, bone marrow toxicity, immune suppression, GI tract damage b/c of fast epithelial overturn (ulceration/decreased absorption=nutritional strain), loss of hair, sores, sterility, nausea, vomiting, possibility of induced cancer |
question
how can drug resistance to chemotherapy occur? |
answer
decreased permeation/increased drug efflux (ex P-glycoprotein in methotrexate and vinicristine), increased intracellular thiol conc., increased activity of DNA repair pathways, and increased rates of metabolism |
question
what is p-glycoprotein? |
answer
a multidrug resistance gene expressed in lots of cancer cells |
question
what are the nitrogen mustards/DNA alkylating agents? how do they work? what are bifunctional alkylating agents? |
answer
cyclophosphamide (prototype), mechlorethamine, ifosamide, chlorambucil. they attach a methyl modality to DNA molecules (guanine is the preference base) and keep it from replicating appropriately. bifunctional alkylating agents can also cause interstrand cross-linking. they are good for solid tumors b/c they are very harsh on DNA so when they do divide, they don't go anywhere |
question
when is meclorethamine used? ADRs? |
answer
meclorethamine is used as a component of MOPP in tx of hodgkins disease, it causes injection site pain, is highly reactive with other drugs and can cause myelosuppression |
question
how is cyclophosphamide metabolized? |
answer
cyclophosphamide is not toxic on its own, it is processed by cytochrome P450 to make toxic metabolites such as aldophosphamide. cancer cells dont have the enzymes to inactivate aldophosphamide, so aldophosphamide becomes acrolein which is cytotoxic (however, not the primary anti tumor species) and can cause hemorrhagic cystitis** and phosphoramide mustard which is the primary antitumor agent. |
question
when is cyclophosphamide used? |
answer
is used for both lymphomas and solid tumors |
question
what kind of drug is cyclophosphamide considered? why is mesna disulfide/predrug hydration coadministered? |
answer
a prodrug. disulfide/predrug hydration coadministered is given to lessen hemorrhagic cystitis from acrolein |
question
what is different about ifosfamide? |
answer
ifosfamide is similar to cyclophosphamide but takes longer/need larger doses to get to ifosfamide mustard. |
question
what is significant about chlorambucil? |
answer
chlorambucil is an alkylating agent that has good bioavailability, is well tolerated on a daily basis and has lower toxicity that can be more easily reversed |
question
what is is chronic myeloid leukemia (CML), and what drugs are used for it? |
answer
CML is a BCR-ABL translocation (phila chr) causing unregulated tyrosine kinase -> unregualted WBCs. busulfan (sulfonate alkylator) was used, not imatinib mesylate is used, which as less side effects and has a higher CML selectivity by inhibiting a portion of the defective enzyme (allows pts to live more comfortably) |
question
what is carmustine? what is it used in? what is an ADR? |
answer
carmustine is a nitrosourea alkylating agent that is highly lipid soluble, and is used in treating hodgkins/non-hodgkins lymphomas, brain cancers, and *meningial leukemias* by causing cross-linking, usually on guanine. it can cause cancer eventually |
question
how do platinum salts such as cisplatin work? ADRs? when are they used? |
answer
platinum salts form covalent intrastrand cross linking of dsDNA (alkylation), keeping it from necessary separation in replication via DNA polymerase. ADRs include nephrotoxicity (monitor creatinine clearance). they are used in solid tumors. ototoxicity/peripheral neuropathy. |
question
what is FOLFOX? |
answer
FOLFOX is a combination of 5-flourouracil and leukovorin (leukovorin is essentially folic acid. this will supplement body with some folate so you do not have as much bone marrow suppression) |
question
what are anthracyclines? |
answer
tetracycline antibx including doxorubicin (most important), daunorubicin, mitoanrone, idarubicin |
question
what is doxorubicin used for? ADRs? |
answer
doxorubicin is widely used for lymphomas, leukemias, and solid tumors. it inhibits topoisomerase II and produces free radicals and is used in a high dose initially with synergistic agents to minimize the # cycles, due to high toxicity, esp w/potential irreverible CHF (blood markers should be monitored) |
question
what is dexrazoxane? |
answer
an agent coadministered with doxorubicin that chelates Fe to prevent iron-mediated free radical generation - reduces cardiotoxicity. this shows how good doxorubicin is for killing cancer if there are drugs being developed to keep its toxicity down |
question
what does bleomycin do? when is it used? ADR? |
answer
bleomycin is an antibiotic that causes DNA strand breaks (formes Fe free radicals) and is used in hodgkins as well as certain testicular/lung CAs. it is associated with dose-related pulmonary fibrosis. |
question
what are examples of antimetabolites? |
answer
methotrexate, 5-FU, mercaptopurine, and cytarabine |
question
what is the M/A for methotrexate (MTX)? |
answer
methotrexate inhibits dihydrofolate reductase (and thymidylate synthase) b/c is is very close to folic acid in structure and competes with it. it exists in a *polyglutamated* form in cells which is too bulky to leave, and has to be eliminated in 2 phases by the renal system. |
question
what is MTX used for? |
answer
MTX is indicated for ALL, NHL, solid tumors as well as RA and psoriasis |
question
what is leucovorin? |
answer
activated folate administered with high dose methotrexate (like w/choriocarcinoma) to avoid severe bone marrow depression |
question
what is significant about methotrexate being a weak acid? |
answer
if MTX levels remain high, nephrotoxicity can result, this can be avoided by alkalinizing urine to ionize and eliminate MTX |
question
what are ADRs for MTX? |
answer
bone marrow suppression, ulcers, and pulmonary fibrosis (not as bad as bleomycin) |
question
what are some drug-drug interactions w/MTX? |
answer
antibx such as sulfonamides/tetracyclines can cause increased toxicity (or other highly plasma protein bound drugs). drugs that compete for tubular secretion such as PCN/cephs, or reduce renal flow (NSAIDs) and keep MTX levels too high. high MTX levels can be adjusted with leukovorin. |
question
what drugs can inhibit both thymidylate synthase? |
answer
methotrexate and 5-FU |
question
what does 5-flourouracil do? when is it used? ADRs? |
answer
5-FU is activated to FdUMP which complexes with tetrahydrofolate to inhibit thymidine synthetase, stopping DNA synthesis. FdUMP also causes miscoding of RNA, making protein translation difficult. is used in solid tumors esp the colon. it can cause bone marrow suppression. |
question
what is mercaptopurine? |
answer
a purine antimetabolite that mimics adenine and causes misreading in DNA, leading to miscoding and faulty translation. |
question
what is cytarabine? |
answer
a pyrimidine that is incorporated and activated into CTP which inhibits DNA polymerase - it is an S phase specific metabolite. |
question
why are purines and pyrimidines analogues good for leukemias and lymphomas? |
answer
because they have rapidly dividing cells |
question
are alkylating agents cell cycle specific agents? |
answer
no |
question
are antimetabolites cell specific agents? |
answer
yes, for S phase |
question
what kind of DNA do alkylators damage? |
answer
preformed DNA via interstrand crosslinks |
question
what kind of DNA do antimetabolites damage? |
answer
new DNA (why they are good for leukemias and lymphomas) |
question
what level of proliferation do alkylators target? |
answer
rapid and slow G0 proliferating cells |
question
what level of proliferation do antimetabolites target? |
answer
just rapidly proliferating cells |
question
of alkylators and antimetabolites, which is more likely to kill BM cells or cause secondary lymphomas/leukemias? |
answer
antimetabolites |
question
of alkylators and antimetabolites, which is more likely to have larger carcinogenic, tetragenic and mutagenic properties? |
answer
alkylators |